Status:
ACTIVE_NOT_RECRUITING
Retinal Biomarkers in Parkinson´s Disease
Lead Sponsor:
Landspitali University Hospital
Collaborating Sponsors:
Reykjalundur Rehabilitation
University of Iceland
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to determine whether oxygen content of the retinal vessels of the eye may serve as a biomarker in Parkinson´s disease. The main questions it aims to answer are:...
Eligibility Criteria
Inclusion
- Confirmed Parkinson Disease
Exclusion
- Eye disease
- Diabetic Mellitus
- Chronic Obstructive Pulmonary Disease (COPD)
- Other Neurological Disease
- Smoking on a daily basis
Key Trial Info
Start Date :
March 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06929026
Start Date
March 10 2023
End Date
December 31 2026
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Outpatient Department Landspitali UH
Reykjavik, Iceland, 101